MARKET

HBIO

HBIO

Harvard Biosci
NASDAQ
5.22
+0.29
+5.88%
After Hours: 5.22 0 0.00% 16:02 12/08 EST
OPEN
4.980
PREV CLOSE
4.930
HIGH
5.30
LOW
4.915
VOLUME
113.27K
TURNOVER
0
52 WEEK HIGH
6.29
52 WEEK LOW
1.980
MARKET CAP
222.83M
P/E (TTM)
-67.1815
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at HBIO last week (1127-1201)?
Weekly Report · 5d ago
Weekly Report: what happened at HBIO last week (1120-1124)?
Weekly Report · 11/27 09:55
Weekly Report: what happened at HBIO last week (1113-1117)?
Weekly Report · 11/20 09:54
Weekly Report: what happened at HBIO last week (1106-1110)?
Weekly Report · 11/13 09:52
Harvard Biosci: Quarterly report
Press release · 11/07 22:08
Harvard Biosci: Current report
Press release · 11/07 14:01
Harvard Bioscience Non-GAAP EPS of $0.01 misses by $0.03, revenue of $25.4M misses by $2.5M
Seeking Alpha · 11/07 12:20
Harvard Bioscience Q3 Adjusted EPS $0.01 Misses $0.04 Estimate, Sales $25.36M Miss $28.02M Estimate
Benzinga · 11/07 12:08
More
About HBIO
Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. It has organized its product line activities into two product families, cellular and molecular technology (CMT) and Preclinical. Its CMT product family is composed of products supporting research related to molecular, cellular organ and organoid technologies, with additional application in the field of bio-production of pharmaceuticals and therapeutics. Its preclinical product family includes four business lines that support the preclinical research and testing phase for drug development, and in particular testing related to data collection and analysis for safety and regulatory compliance. Its brands include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs and others.

Webull offers Harvard Bioscience, Inc. stock information, including NASDAQ: HBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HBIO stock methods without spending real money on the virtual paper trading platform.